Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 156

    1.

    Clinical outcome in children with recurrent neuroblastoma treated with ABT-751 and effect of ABT-751 on proliferation of neuroblastoma cell lines and on tubulin polymerization in vitro.

    Meany HJ, Sackett DL, Maris JM, Ward Y, Krivoshik A, Cohn SL, Steinberg SM, Balis FM, Fox E.

    Pediatr Blood Cancer. 2010 Jan;54(1):47-54.PMID: 19731320 [PubMed - in process]Related articles

    2.

    Are molecular neuroblastoma classifiers ready for prime time?

    Volchenboum SL, Cohn SL.

    Lancet Oncol. 2009 Jul;10(7):641-2. No abstract available. PMID: 19573794 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prophylaxis of venous thromboembolism in the US: improving hospital performance.

    Cohn SL.

    J Thromb Haemost. 2009 Sep;7(9):1437-45. Epub 2009 Jun 27.PMID: 19566791 [PubMed - in process]Related articles

    4.

    Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

    Okamatsu C, London WB, Naranjo A, Hogarty MD, Gastier-Foster JM, Look AT, LaQuaglia M, Maris JM, Cohn SL, Matthay KK, Seeger RC, Saji T, Shimada H.

    Pediatr Blood Cancer. 2009 Oct;53(4):563-9.PMID: 19530234 [PubMed - indexed for MEDLINE]Related articles

    5.

    Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.

    Zeine R, Salwen HR, Peddinti R, Tian Y, Guerrero L, Yang Q, Chlenski A, Cohn SL.

    Mod Pathol. 2009 Jul;22(7):950-8. Epub 2009 May 1.PMID: 19407854 [PubMed - indexed for MEDLINE]Related articles

    6.

    International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, Maris JM.

    Br J Cancer. 2009 May 5;100(9):1471-82.PMID: 19401703 [PubMed - indexed for MEDLINE]Related articles

    7.

    Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force.

    Beiske K, Burchill SA, Cheung IY, Hiyama E, Seeger RC, Cohn SL, Pearson AD, Matthay KK; International neuroblastoma Risk Group Task Force.

    Br J Cancer. 2009 May 19;100(10):1627-37. Epub 2009 Apr 28.PMID: 19401690 [PubMed - indexed for MEDLINE]Related articles

    8.

    Progress in defining and treating high-risk neuroblastoma: lessons from the bench and bedside.

    Volchenboum SL, Cohn SL.

    J Clin Oncol. 2009 Mar 1;27(7):1003-4. Epub 2009 Jan 26. No abstract available. PMID: 19171702 [PubMed - indexed for MEDLINE]Related articles

    9.

    The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

    Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin D, Mosseri V, Simon T, Garaventa A, Castel V, Matthay KK; INRG Task Force.

    J Clin Oncol. 2009 Jan 10;27(2):289-97. Epub 2008 Dec 1.PMID: 19047291 [PubMed - indexed for MEDLINE]Related articles

    10.

    The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report.

    Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, Cohn SL, Pearson AD; INRG Task Force.

    J Clin Oncol. 2009 Jan 10;27(2):298-303. Epub 2008 Dec 1.PMID: 19047290 [PubMed - indexed for MEDLINE]Related articles

    11.

    Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

    Bagatell R, Beck-Popovic M, London WB, Zhang Y, Pearson AD, Matthay KK, Monclair T, Ambros PF, Cohn SL; International Neuroblastoma Risk Group.

    J Clin Oncol. 2009 Jan 20;27(3):365-70. Epub 2008 Dec 1.PMID: 19047282 [PubMed - indexed for MEDLINE]Related articles

    12.

    Perioperative cardiac evaluation: assessment, risk reduction, and complication management.

    Mauck KF, Manjarrez EC, Cohn SL.

    Clin Geriatr Med. 2008 Nov;24(4):585-605, vii. Review.PMID: 18984375 [PubMed - indexed for MEDLINE]Related articles

    13.

    Management of tumor lysis syndrome: need for evidence-based guidelines.

    Feusner JH, Ritchey AK, Cohn SL, Billett AL.

    J Clin Oncol. 2008 Dec 1;26(34):5657-8; author reply 5658-9. Epub 2008 Nov 3. No abstract available. PMID: 18981455 [PubMed - indexed for MEDLINE]Related articles

    14.

    Lung metastases in neuroblastoma at initial diagnosis: A report from the International Neuroblastoma Risk Group (INRG) project.

    Dubois SG, London WB, Zhang Y, Matthay KK, Monclair T, Ambros PF, Cohn SL, Pearson A, Diller L.

    Pediatr Blood Cancer. 2008 Nov;51(5):589-92.PMID: 18649370 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Preoperative cardiac evaluation of lung resection candidates.

    Cohn SL.

    Thorac Surg Clin. 2008 Feb;18(1):45-59. Review.PMID: 18402201 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.

    Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, Cohn SL.

    J Clin Oncol. 2008 Feb 20;26(6):913-8.PMID: 18281664 [PubMed - indexed for MEDLINE]Related articles

    17.

    A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors.

    Fox E, Maris JM, Widemann BC, Goodspeed W, Goodwin A, Kromplewski M, Fouts ME, Medina D, Cohn SL, Krivoshik A, Hagey AE, Adamson PC, Balis FM.

    Clin Cancer Res. 2008 Feb 15;14(4):1111-5.PMID: 18281544 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    3 + 3 not equal to (Rolling) 6.

    Hartford C, Volchenboum SL, Cohn SL.

    J Clin Oncol. 2008 Jan 10;26(2):170-1. No abstract available. PMID: 18182656 [PubMed - indexed for MEDLINE]Related articles

    19.

    Update in perioperative medicine.

    Cohn SL, Smetana GW.

    Ann Intern Med. 2007 Aug 21;147(4):263-70. Review. No abstract available. PMID: 17709760 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    School-based practice: physical therapists collaborating with physical education teachers. Give it a try!

    Cohn SL.

    Phys Occup Ther Pediatr. 2007;27(3):4. No abstract available. PMID: 17613452 [PubMed - indexed for MEDLINE]Related articles

    21.

    Neuroblastoma.

    Maris JM, Hogarty MD, Bagatell R, Cohn SL.

    Lancet. 2007 Jun 23;369(9579):2106-20. Review.PMID: 17586306 [PubMed - indexed for MEDLINE]Related articles

    22.

    Prominent microvascular proliferation in clinically aggressive neuroblastoma.

    Peddinti R, Zeine R, Luca D, Seshadri R, Chlenski A, Cole K, Pawel B, Salwen HR, Maris JM, Cohn SL.

    Clin Cancer Res. 2007 Jun 15;13(12):3499-506.PMID: 17575212 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Preoperative cardiac risk stratification 2007: evolving evidence, evolving strategies.

    Cohn SL, Auerbach AD.

    J Hosp Med. 2007 May;2(3):174-80. Review.PMID: 17549772 [PubMed - indexed for MEDLINE]Related articles

    24.

    Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.

    Yang Q, Kiernan CM, Tian Y, Salwen HR, Chlenski A, Brumback BA, London WB, Cohn SL.

    Clin Cancer Res. 2007 Jun 1;13(11):3191-7.PMID: 17545522 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    High-resolution analysis of 3p deletion in neuroblastoma and differential methylation of the SEMA3B tumor suppressor gene.

    Nair PN, McArdle L, Cornell J, Cohn SL, Stallings RL.

    Cancer Genet Cytogenet. 2007 Apr 15;174(2):100-10.PMID: 17452250 [PubMed - indexed for MEDLINE]Related articles

    26.

    Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.

    Yang Q, Tian Y, Liu S, Zeine R, Chlenski A, Salwen HR, Henkin J, Cohn SL.

    Cancer Res. 2007 Feb 15;67(4):1716-24.PMID: 17308113 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    SPARC enhances tumor stroma formation and prevents fibroblast activation.

    Chlenski A, Guerrero LJ, Yang Q, Tian Y, Peddinti R, Salwen HR, Cohn SL.

    Oncogene. 2007 Jul 5;26(31):4513-22. Epub 2007 Jan 29.PMID: 17260013 [PubMed - indexed for MEDLINE]Related articles

    28.

    Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention.

    Cohn SL, Adekile A, Mahabir V.

    J Hosp Med. 2006 Nov;1(6):331-8.PMID: 17219525 [PubMed - indexed for MEDLINE]Related articles

    29.

    Update in perioperative medicine.

    Smetana GW, Cohn SL, Mercado DL, Jaffer AK.

    J Gen Intern Med. 2006 Dec;21(12):1329-37. No abstract available. PMID: 17105527 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study.

    Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, Maris JM, Diller L, Look AT, George RE.

    Clin Cancer Res. 2006 Oct 1;12(19):5693-7.PMID: 17020972 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.

    Fox E, Maris JM, Widemann BC, Meek K, Goodwin A, Goodspeed W, Kromplewski M, Fouts ME, Medina D, Cho SY, Cohn SL, Krivoshik A, Hagey AE, Adamson PC, Balis FM.

    Clin Cancer Res. 2006 Aug 15;12(16):4882-7.PMID: 16914576 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.

    Burke MJ, Cohn SL.

    Pediatr Blood Cancer. 2008 Mar;50(3):679-80.PMID: 16900484 [PubMed - indexed for MEDLINE]Related articles

    33.

    Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.

    Haber M, Smith J, Bordow SB, Flemming C, Cohn SL, London WB, Marshall GM, Norris MD.

    J Clin Oncol. 2006 Apr 1;24(10):1546-53.PMID: 16575006 [PubMed - indexed for MEDLINE]Related articles

    34.

    Cardiac risk stratification before noncardiac surgery.

    Cohn SL.

    Cleve Clin J Med. 2006 Mar;73 Suppl 1:S18-24. Review.PMID: 16570543 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    The MYCN enigma: significance of MYCN expression in neuroblastoma.

    Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N.

    Cancer Res. 2006 Mar 1;66(5):2826-33.PMID: 16510605 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: saving for a rainy day.

    Grupp SA, Cohn SL, Wall D, Reynolds CP; Hematopoietic Stem Cell Transplant Discipline and the Neuroblastoma Disease Committee, Children's Oncology Group.

    Pediatr Blood Cancer. 2006 Jun;46(7):719-22. Review.PMID: 16429413 [PubMed - indexed for MEDLINE]Related articles

    37.

    Excellent local tumor control regardless of extent of surgical resection after treatment on the Chicago Pilot II protocol for neuroblastoma.

    Browne M, Kletzel M, Cohn SL, Seshadri R, Reynolds M.

    J Pediatr Surg. 2006 Jan;41(1):271-6.PMID: 16410146 [PubMed - indexed for MEDLINE]Related articles

    38.

    Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.

    Bagatell R, Rumcheva P, London WB, Cohn SL, Look AT, Brodeur GM, Frantz C, Joshi V, Thorner P, Rao PV, Castleberry R, Bowman LC.

    J Clin Oncol. 2005 Dec 1;23(34):8819-27.PMID: 16314642 [PubMed - indexed for MEDLINE]Related articles

    39.

    Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group.

    N Engl J Med. 2005 Nov 24;353(21):2243-53.PMID: 16306521 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.

    London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL.

    J Clin Oncol. 2005 Sep 20;23(27):6459-65. Epub 2005 Aug 22.PMID: 16116153 [PubMed - indexed for MEDLINE]Related articles

    41.

    Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.

    George RE, London WB, Cohn SL, Maris JM, Kretschmar C, Diller L, Brodeur GM, Castleberry RP, Look AT.

    J Clin Oncol. 2005 Sep 20;23(27):6466-73. Epub 2005 Aug 22.PMID: 16116152 [PubMed - indexed for MEDLINE]Related articles

    42.

    SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.

    Chlenski A, Liu S, Guerrero LJ, Yang Q, Tian Y, Salwen HR, Zage P, Cohn SL.

    Int J Cancer. 2006 Jan 15;118(2):310-6.PMID: 16052522 [PubMed - indexed for MEDLINE]Related articles

    43.

    The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.

    London WB, Boni L, Simon T, Berthold F, Twist C, Schmidt ML, Castleberry RP, Matthay KK, Cohn SL, De Bernardi B.

    Cancer Lett. 2005 Oct 18;228(1-2):257-66. Review.PMID: 16024170 [PubMed - indexed for MEDLINE]Related articles

    44.

    The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome.

    Pajic M, Norris MD, Cohn SL, Haber M.

    Cancer Lett. 2005 Oct 18;228(1-2):241-6. Review.PMID: 15979785 [PubMed - indexed for MEDLINE]Related articles

    45.

    Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.

    De Bernardi B, Balwierz W, Bejent J, Cohn SL, Garrè ML, Iehara T, Plantaz D, Simon T, Angelini P, Cama A, London WB, Kramer K, Katzenstein HM, Tortori-Donati P, Rossi A, D'Angio GJ, Evans AE.

    Cancer Lett. 2005 Oct 18;228(1-2):283-99. Review.PMID: 15975710 [PubMed - indexed for MEDLINE]Related articles

    46.

    Protocol for the examination of specimens from patients with neuroblastoma and related neuroblastic tumors.

    Qualman SJ, Bowen J, Fitzgibbons PL, Cohn SL, Shimada H; Cancer Committee, College of American Pathologists.

    Arch Pathol Lab Med. 2005 Jul;129(7):874-83. Review. No abstract available. PMID: 15974810 [PubMed - indexed for MEDLINE]Related articles

    47.

    'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.

    Liu S, Tian Y, Chlenski A, Yang Q, Salwen HR, Cohn SL.

    Cancer Lett. 2005 Oct 18;228(1-2):125-31. Review.PMID: 15935552 [PubMed - indexed for MEDLINE]Related articles

    48.

    Stroke prevention in atrial fibrillation: current anticoagulation management and future directions.

    Fitzgerald BT, Cohn SL, Klein AL.

    Cleve Clin J Med. 2005 Apr;72 Suppl 1:S24-30. Review.PMID: 15853176 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro.

    Norris MD, Smith J, Tanabe K, Tobin P, Flemming C, Scheffer GL, Wielinga P, Cohn SL, London WB, Marshall GM, Allen JD, Haber M.

    Mol Cancer Ther. 2005 Apr;4(4):547-53.PMID: 15827327 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.

    Liu S, Tian Y, Chlenski A, Yang Q, Zage P, Salwen HR, Crawford SE, Cohn SL.

    Am J Pathol. 2005 Mar;166(3):891-900.PMID: 15743800 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...